Federated Hermes’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
6,041
+5,417
+868% +$1.35M ﹤0.01% 1047
2025
Q4
$150K Sell
624
-2
-0.3% -$511 ﹤0.01% 1540
2025
Q3
$171K Sell
626
-12
-2% -$3.28K ﹤0.01% 1526
2025
Q2
$165K Sell
638
-7
-1% -$1.67K ﹤0.01% 1522
2025
Q1
$144K Sell
645
-492
-43% -$115K ﹤0.01% 1545
2024
Q4
$260K Buy
1,137
+365
+47% +$87.9K ﹤0.01% 1446
2024
Q3
$188K Sell
772
-1,714
-69% -$383K ﹤0.01% 1493
2024
Q2
$476K Sell
2,486
-134
-5% -$27.2K ﹤0.01% 1325
2024
Q1
$519K Buy
2,620
+2,458
+1,517% +$450K ﹤0.01% 1311
2023
Q4
$27.9K Sell
162
-715
-82% -$110K ﹤0.01% 1715
2023
Q3
$130K Sell
877
-16,058
-95% -$2.9M ﹤0.01% 1574
2023
Q2
$3.7M Buy
16,935
+5,236
+45% +$1.17M 0.01% 778
2023
Q1
$2.56M Buy
11,699
+11,105
+1,870% +$2.41M 0.01% 876
2022
Q4
$124K Buy
594
+72
+14% +$15.8K ﹤0.01% 1617
2022
Q3
$114K Buy
522
+37
+8% +$8.42K ﹤0.01% 1600
2022
Q2
$102K Sell
485
-95
-16% -$20.2K ﹤0.01% 1611
2022
Q1
$141K Buy
580
+38
+7% +$9.19K ﹤0.01% 1623
2021
Q4
$141K Sell
542
-756
-58% -$196K ﹤0.01% 1675
2021
Q3
$342K Sell
1,298
-194
-13% -$53K ﹤0.01% 1581
2021
Q2
$368K Sell
1,492
-36,210
-96% -$7.61M ﹤0.01% 1581
2021
Q1
$7.32M Buy
37,702
+8,803
+30% +$1.77M 0.01% 750
2020
Q4
$6.14M Buy
28,899
+6,192
+27% +$1.23M 0.01% 755
2020
Q3
$3.89M Buy
22,707
+8,532
+60% +$1.58M 0.01% 787
2020
Q2
$2.72M Sell
14,175
-66,401
-82% -$10.9M 0.01% 878
2020
Q1
$11.9M Buy
80,576
+79,069
+5,247% +$12.6M 0.03% 438
2019
Q4
$233K Sell
1,507
-33
-2% -$4.76K ﹤0.01% 1586
2019
Q3
$208K Buy
1,540
+984
+177% +$129K ﹤0.01% 1576
2019
Q2
$68K Sell
556
-8,685
-94% -$962K ﹤0.01% 1641
2019
Q1
$961K Sell
9,241
-73,902
-89% -$7.63M ﹤0.01% 1325
2018
Q4
$9.47M Buy
83,143
+81,443
+4,791% +$8.73M 0.03% 512
2018
Q3
$196K Sell
1,700
-98
-5% -$10.7K ﹤0.01% 1605
2018
Q2
$186K Sell
1,798
-549
-23% -$55.5K ﹤0.01% 1549
2018
Q1
$231K Sell
2,347
-668
-22% -$63.1K ﹤0.01% 1496
2017
Q4
$255K Buy
3,015
+2,823
+1,470% +$233K ﹤0.01% 1480
2017
Q3
$15K Sell
192
-69,739
-100% -$5.33M ﹤0.01% 1787
2017
Q2
$5.45M Sell
69,931
-5,480
-7% -$392K 0.02% 549
2017
Q1
$5.43M Sell
75,411
-720
-0.9% -$49.8K 0.02% 556
2016
Q4
$4.72M Sell
76,131
-2,032
-3% -$124K 0.01% 576
2016
Q3
$5.06M Sell
78,163
-2,109
-3% -$140K 0.01% 562
2016
Q2
$5.08M Buy
80,272
+2,519
+3% +$148K 0.01% 554
2016
Q1
$4.5M Sell
77,753
-1,987
-2% -$112K 0.01% 571
2015
Q4
$4.28M Sell
79,740
-3,541
-4% -$200K 0.01% 609
2015
Q3
$4.24M Sell
83,281
-6,436
-7% -$346K 0.01% 609
2015
Q2
$5.06M Buy
89,717
+8,306
+10% +$524K 0.02% 605
2015
Q1
$5.84M Buy
81,411
+4,400
+6% +$286K 0.02% 567
2014
Q4
$4.32M Sell
77,011
-3,278
-4% -$171K 0.01% 661
2014
Q3
$3.96M Sell
80,289
-1,420
-2% -$72.3K 0.01% 721
2014
Q2
$4.14M Sell
81,709
-16,726
-17% -$829K 0.01% 705
2014
Q1
$4.4M Sell
98,435
-28,586
-23% -$1.28M 0.01% 671
2013
Q4
$5.98M Sell
127,021
-32,761
-21% -$1.66M 0.02% 580
2013
Q3
$8.44M Sell
159,782
-10,838
-6% -$526K 0.03% 426
2013
Q2
$7.7M Buy
+170,620
New +$8.1M 0.03% 435

Other funds holding RMD

Federated Hermes's RMD Position: Q1 2026 in Review

Federated Hermes increased its ResMed (RMD) stake by 868% in Q1 2026, buying an estimated $1.35M and bringing the position to 6,041 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Federated Hermes first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q1 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Federated Hermes held 6,041 shares of ResMed worth $1.36M as of Q1 2026.
  • Federated Hermes bought 5,417 ResMed shares in Q1 2026, an estimated $1.35M.
  • ResMed made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1047 holding.
  • Federated Hermes first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's ResMed position peaked at $11.9M in Q1 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.